STJ Related Analyst Ratings
-
RBC Capital Downgrades St. Jude Medical (STJ) to Underperform
-
Cowen Upgrades St. Jude Medical (STJ) to Underperform
-
Credit Suisse Upgrades St. Jude Medical (STJ) to Outperform
-
St. Jude Medical (STJ) Warning Letter 'Anticipated', Questions Remain
-
BMO Capital Downgrades St. Jude Medical (STJ) to Market Perform
-
Mizuho Securities Upgrades St. Jude Medical (STJ) to Buy
-
St. Jude (STJ) Durata Recall Unlikely - Analyst
-
Notable Analyst Rating Changes 11/21: (PENN) (THOR) (SKX) Upgraded; (HTWR) (EV) (ICA) Downgraded
-
Wells Fargo Downgrades St. Jude Medical (STJ) to Market Perform
-
Stifel Nicolaus Starts St. Jude Medical (STJ) at Hold
-
Morgan Stanley Downgrades St. Jude Medical (STJ) to Equalweight
-
Credit Suisse Downgrades St. Jude Medical (STJ) to Neutral
-
UPDATE: Canaccord Genuity Downgrades St. Jude Medical (STJ) to Hold, Weak Top-Line
-
William Blair Downgrades St. Jude Medical (STJ) to Market Perform
-
Goldman Sachs Downgrades St. Jude Medical (STJ) to Neutral, Growth Deferred
-
Mizuho Securities Downgrades St. Jude Medical (STJ) to Neutral
-
Restructuring, Weak Dollar Prompts Wells Fargo to Upgrades St. Jude Medical (STJ) to Outperform
-
Canaccord Genuity Maintains a 'Buy' on St. Jude Medical (STJ); The FDA 'PR' Move
-
Jefferies Q2 Review on St. Jude Medical (STJ): Not Terribly Confidence-Inspiring
-
Canaccord Genuity Reiterates a 'Buy' on St. Jude Medical (STJ); Recommend Adding to Positions
-
Goldman Sachs Recommends Buying St. Jude Medical (STJ) On Recent Weakness
-
Lazard Capital Upgrades St. Jude Medical (STJ) to Buy
-
Canaccord Genuity Maintains a 'Buy' on St. Jude Medical (STJ); Shares Already Reflect Moderate Degree of Pessimism
-
Barclays on Medical Supplies & Devices: Continue To Favor Stocks with Potential Product Catalyst (STJ, THOR, HWTR & NUVA)
-
Goldman Sachs Upgrades St. Jude Medical (STJ) to Buy
-
Morgan Stanley Upgrades St. Jude Medical (STJ) to Overweight
-
Canaccord Genuity Maintains a 'Buy' on St. Jude Medical (NYSE: STJ); Buy on Weakness
-
Canaccord Genuity Maintains a 'Buy' on St. Jude Medical (STJ); Stock Up Ahead of Q1 Results
-
Analysts See More Concerns as Another Lead Issue (QuickSite/QuickFlex) Casts Larger Shadow Over St. Jude (STJ)
-
Lazard Downgrades ISRG, AGN, ELGX, STJ, ZOLL to Neutral
-
Northland Starts BSX, STAA, IART at Outperform, MDT, STJ, VOLC at Market Perform
-
UBS Reiterates a 'Buy' on St. Jude Medical (STJ); Positive After Analyst Meeting
-
Canaccord Genuity Maintains a 'Buy' on St. Jude Medical (STJ); Positive After Analyst Day
-
Jefferies Maintains a 'Hold' on St. Jude Medical (STJ); 2012 A Bet On CRM
-
Canaccord Genuity Upgrades St. Jude Medical (STJ) to Buy; Favorable Risk/Reward + Guidance Seems Conservative
-
Canaccord Genuity Q4 Med-Tech Preview: Best Ideas (HTWR & EW)
-
Bernstein Upgrades St. Jude Medical (STJ) to Outperform
-
Kaufman Bros. on Medical Technology - Keeping Things Simple as We Enter 2012
-
Jefferies Cuts Price Target on Kensey Nash (KNSY), Sees St. Jude (STJ) Winning
-
Barclays Reiterates an 'Overweight' on St. Jude Medical (STJ); No New Info in FDA's Riata Classification
-
Deutsche Cuts Price Target on St. Jude Medical (STJ) Due to Weakness in Euro
-
Jefferies Downgrades St. Jude Medical (STJ) to Hold
-
Barclays Maintains an 'Overweight' on St. Jude Medical (STJ); Panel Disappoints - Thoughts on CardioMEMS
-
Jefferies Cuts Price Target on St. Jude Medical (STJ) Following FDA Vote on CardioMEMS
-
Barclays Maintains an 'Overweight' on St. Jude Medical (STJ); CardioMEMS Preview & Guidebook
-
Highlights From Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Conference Part III
-
Barclays on Medical Supplies & Devices: 3Q11 Review; Preliminary 2012 Outlook
-
Barclays Reiterates an 'Overweight' on St. Jude Medical (STJ); Quadra Approval + Riata Response = Relief
-
Canaccord Genuity Maintains a 'Hold' on St. Jude Medical (STJ); Quadra Approved; Doctor Letter Updates Riata
-
UBS Maintains a 'Buy' on St. Jude Medical (STJ); Cautious Doc Feedback on Riata / Durata
Back to STJ Stock Lookup
